Related Experiment Video
Updated: Jan 22, 2026
03:42
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
2.0K
Heart failure with preserved ejection fraction: A growing global epidemic
Pyi Naing1, Douglas Forrester2, Nadarajah Kangaharan3
1MBBS, MPhil, GDipEcho, Senior Registrar, Royal Darwin Hospital, NT; MPhil Candidate, University of Notre Dame Australia (Fremantle), WA; Associate Lecturer, Flinders University, SA. kopyinaing@gmail.com.
Australian Journal of General Practice
|July 1, 2019
Summary
Heart failure with preserved ejection fraction (HFpEF) is a growing global concern with a prognosis similar to HFrEF. Early diagnosis and prevention are key due to limited treatment options for this common condition.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Heart failure with preserved ejection fraction (HFpEF) is a significant and underrecognized global health issue.
- HFpEF affects approximately half of all heart failure patients, presenting a prognosis comparable to heart failure with reduced ejection fraction (HFrEF).
Observation:
- HFpEF symptoms like dyspnoea and fluid retention can mimic HFrEF, complicating clinical diagnosis.
- Key risk factors for HFpEF include advanced age, obesity, hypertension, diabetes, chronic kidney disease, and obstructive sleep apnea.
- Diagnosis relies on clinical assessment, echocardiography, and elevated B-type natriuretic peptide levels.
Findings:
- Current management strategies for advanced HFpEF are challenging due to a lack of evidence-based therapies.
- Prevention and early detection are crucial for managing the growing epidemic of HFpEF.
Implications:
- This review highlights the need for increased awareness and timely diagnosis of HFpEF.
- Further research into effective, evidence-based treatments for HFpEF is essential.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
790
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
790
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
729
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
729
01:22Heart Failure VI: Adjunct Therapies
278
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
278
01:22Heart Failure Drugs: Diuretics
825
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
825
01:30Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227